GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Farmaceutica Remedia SA (BSE:RMAH) » Definitions » Cyclically Adjusted Book per Share

Farmaceutica Remedia (BSE:RMAH) Cyclically Adjusted Book per Share : lei0.61 (As of Mar. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Farmaceutica Remedia Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Farmaceutica Remedia's adjusted book value per share for the three months ended in Mar. 2024 was lei0.544. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is lei0.61 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Farmaceutica Remedia's average Cyclically Adjusted Book Growth Rate was 7.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2024-06-24), Farmaceutica Remedia's current stock price is lei0.746. Farmaceutica Remedia's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was lei0.61. Farmaceutica Remedia's Cyclically Adjusted PB Ratio of today is 1.22.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Farmaceutica Remedia was 2.17. The lowest was 1.05. And the median was 1.18.


Farmaceutica Remedia Cyclically Adjusted Book per Share Historical Data

The historical data trend for Farmaceutica Remedia's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Farmaceutica Remedia Cyclically Adjusted Book per Share Chart

Farmaceutica Remedia Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.50 0.56 0.60

Farmaceutica Remedia Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.57 0.58 0.59 0.60 0.61

Competitive Comparison of Farmaceutica Remedia's Cyclically Adjusted Book per Share

For the Medical Distribution subindustry, Farmaceutica Remedia's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Farmaceutica Remedia's Cyclically Adjusted PB Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Farmaceutica Remedia's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Farmaceutica Remedia's Cyclically Adjusted PB Ratio falls into.



Farmaceutica Remedia Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Farmaceutica Remedia's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.544/131.7762*131.7762
=0.544

Current CPI (Mar. 2024) = 131.7762.

Farmaceutica Remedia Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.377 100.560 0.494
201409 0.396 100.428 0.520
201412 0.393 99.070 0.523
201503 0.398 99.621 0.526
201506 0.369 100.684 0.483
201509 0.373 100.392 0.490
201512 0.371 99.792 0.490
201603 0.370 100.470 0.485
201606 0.374 101.688 0.485
201609 0.375 101.861 0.485
201612 0.386 101.863 0.499
201703 0.397 102.862 0.509
201706 0.393 103.349 0.501
201709 0.408 104.136 0.516
201712 0.422 104.011 0.535
201803 0.443 105.290 0.554
201806 0.435 106.317 0.539
201809 0.436 106.507 0.539
201812 0.440 105.998 0.547
201903 0.448 107.251 0.550
201906 0.444 108.070 0.541
201909 0.441 108.329 0.536
201912 0.464 108.420 0.564
202003 0.455 108.902 0.551
202006 0.401 108.767 0.486
202009 0.709 109.815 0.851
202012 0.755 109.897 0.905
202103 0.718 111.754 0.847
202106 0.655 114.631 0.753
202109 0.677 115.734 0.771
202112 0.717 117.630 0.803
202203 0.691 121.301 0.751
202206 0.669 125.017 0.705
202209 0.698 125.227 0.735
202212 0.719 125.222 0.757
202303 0.716 127.348 0.741
202306 0.661 128.729 0.677
202309 0.700 129.860 0.710
202312 0.744 129.419 0.758
202403 0.544 131.776 0.544

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Farmaceutica Remedia  (BSE:RMAH) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Farmaceutica Remedia's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.746/0.61
=1.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Farmaceutica Remedia was 2.17. The lowest was 1.05. And the median was 1.18.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Farmaceutica Remedia Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Farmaceutica Remedia's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Farmaceutica Remedia (BSE:RMAH) Business Description

Traded in Other Exchanges
N/A
Address
No. 2 Nicolae Balcescu Boulevard, Hunedoara County, Deva, ROU, 330040
Farmaceutica Remedia SA is engaged in drug sales activities, marketing, and health products. It provides marketing and promotion services for medicines. The company offers services offered, including logistics services, medical marketing, and promotion, and pharmaceutical registrations, but also professionalism and performance differentiate the company from other competitors and position it as a partner for launching, promoting, and distributing pharmaceutical products in Romania and other countries in Eastern Europe.

Farmaceutica Remedia (BSE:RMAH) Headlines

No Headlines